世界のメトホルミンｰピオグリタゾン市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metformin-Pioglitazone Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5860
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、95ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、メトホルミンｰピオグリタゾンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤：15mgピオグリタゾン/1000mgメトホルミンHCl、錠剤：30mgピオグリタゾン/1000mgメトホルミンHCl）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・メトホルミンｰピオグリタゾンの市場動向
・企業の競争状況、市場シェア
・メトホルミンｰピオグリタゾンの種類別市場規模と予測2016-2027（錠剤：15mgピオグリタゾン/1000mgメトホルミンHCl、錠剤：30mgピオグリタゾン/1000mgメトホルミンHCl）
・メトホルミンｰピオグリタゾンの用途別市場規模と予測2016-2027（病院、ドラッグストア）
・メトホルミンｰピオグリタゾンの北米市場規模2016-2027（アメリカ、カナダ）
・メトホルミンｰピオグリタゾンの欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・メトホルミンｰピオグリタゾンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・メトホルミンｰピオグリタゾンの中南米市場規模2016-2027（メキシコ、ブラジル）
・メトホルミンｰピオグリタゾンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Takeda Pharmaceuticals、Mylan、Teva、Sandoz、Aurobindo Pharma、MACLEODS、Torrent Pharmaceuticals）
・結論

Metformin/pioglitazone is used to lower blood sugar levels in type 2 diabetes. It’s used along with diet and exercise.

Market Analysis and Insights: Global Metformin-Pioglitazone Market
The global Metformin-Pioglitazone market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metformin-Pioglitazone market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metformin-Pioglitazone market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metformin-Pioglitazone market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metformin-Pioglitazone market.

Global Metformin-Pioglitazone Scope and Market Size
Metformin-Pioglitazone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metformin-Pioglitazone market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Tablets: 15 mg pioglitazone/1000 mg metformin HCl
Tablets: 30 mg pioglitazone/1000 mg metformin HCl

Segment by Application
Hospital
Drug store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Takeda Pharmaceuticals
Mylan
Teva
Sandoz
Aurobindo Pharma
MACLEODS
Torrent Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metformin-Pioglitazone Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Tablets: 15 mg pioglitazone/1000 mg metformin HCl
1.2.3 Tablets: 30 mg pioglitazone/1000 mg metformin HCl
1.3 Market by Application
1.3.1 Global Metformin-Pioglitazone Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metformin-Pioglitazone Market Perspective (2016-2027)
2.2 Metformin-Pioglitazone Growth Trends by Regions
2.2.1 Metformin-Pioglitazone Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metformin-Pioglitazone Historic Market Share by Regions (2016-2021)
2.2.3 Metformin-Pioglitazone Forecasted Market Size by Regions (2022-2027)
2.3 Metformin-Pioglitazone Industry Dynamic
2.3.1 Metformin-Pioglitazone Market Trends
2.3.2 Metformin-Pioglitazone Market Drivers
2.3.3 Metformin-Pioglitazone Market Challenges
2.3.4 Metformin-Pioglitazone Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metformin-Pioglitazone Players by Revenue
3.1.1 Global Top Metformin-Pioglitazone Players by Revenue (2016-2021)
3.1.2 Global Metformin-Pioglitazone Revenue Market Share by Players (2016-2021)
3.2 Global Metformin-Pioglitazone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metformin-Pioglitazone Revenue
3.4 Global Metformin-Pioglitazone Market Concentration Ratio
3.4.1 Global Metformin-Pioglitazone Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metformin-Pioglitazone Revenue in 2020
3.5 Metformin-Pioglitazone Key Players Head office and Area Served
3.6 Key Players Metformin-Pioglitazone Product Solution and Service
3.7 Date of Enter into Metformin-Pioglitazone Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metformin-Pioglitazone Breakdown Data by Type
4.1 Global Metformin-Pioglitazone Historic Market Size by Type (2016-2021)
4.2 Global Metformin-Pioglitazone Forecasted Market Size by Type (2022-2027)

5 Metformin-Pioglitazone Breakdown Data by Application
5.1 Global Metformin-Pioglitazone Historic Market Size by Application (2016-2021)
5.2 Global Metformin-Pioglitazone Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metformin-Pioglitazone Market Size (2016-2027)
6.2 North America Metformin-Pioglitazone Market Size by Type
6.2.1 North America Metformin-Pioglitazone Market Size by Type (2016-2021)
6.2.2 North America Metformin-Pioglitazone Market Size by Type (2022-2027)
6.2.3 North America Metformin-Pioglitazone Market Size by Type (2016-2027)
6.3 North America Metformin-Pioglitazone Market Size by Application
6.3.1 North America Metformin-Pioglitazone Market Size by Application (2016-2021)
6.3.2 North America Metformin-Pioglitazone Market Size by Application (2022-2027)
6.3.3 North America Metformin-Pioglitazone Market Size by Application (2016-2027)
6.4 North America Metformin-Pioglitazone Market Size by Country
6.4.1 North America Metformin-Pioglitazone Market Size by Country (2016-2021)
6.4.2 North America Metformin-Pioglitazone Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Metformin-Pioglitazone Market Size (2016-2027)
7.2 Europe Metformin-Pioglitazone Market Size by Type
7.2.1 Europe Metformin-Pioglitazone Market Size by Type (2016-2021)
7.2.2 Europe Metformin-Pioglitazone Market Size by Type (2022-2027)
7.2.3 Europe Metformin-Pioglitazone Market Size by Type (2016-2027)
7.3 Europe Metformin-Pioglitazone Market Size by Application
7.3.1 Europe Metformin-Pioglitazone Market Size by Application (2016-2021)
7.3.2 Europe Metformin-Pioglitazone Market Size by Application (2022-2027)
7.3.3 Europe Metformin-Pioglitazone Market Size by Application (2016-2027)
7.4 Europe Metformin-Pioglitazone Market Size by Country
7.4.1 Europe Metformin-Pioglitazone Market Size by Country (2016-2021)
7.4.2 Europe Metformin-Pioglitazone Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metformin-Pioglitazone Market Size (2016-2027)
8.2 Asia-Pacific Metformin-Pioglitazone Market Size by Type
8.2.1 Asia-Pacific Metformin-Pioglitazone Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metformin-Pioglitazone Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metformin-Pioglitazone Market Size by Type (2016-2027)
8.3 Asia-Pacific Metformin-Pioglitazone Market Size by Application
8.3.1 Asia-Pacific Metformin-Pioglitazone Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metformin-Pioglitazone Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metformin-Pioglitazone Market Size by Application (2016-2027)
8.4 Asia-Pacific Metformin-Pioglitazone Market Size by Region
8.4.1 Asia-Pacific Metformin-Pioglitazone Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metformin-Pioglitazone Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metformin-Pioglitazone Market Size (2016-2027)
9.2 Latin America Metformin-Pioglitazone Market Size by Type
9.2.1 Latin America Metformin-Pioglitazone Market Size by Type (2016-2021)
9.2.2 Latin America Metformin-Pioglitazone Market Size by Type (2022-2027)
9.2.3 Latin America Metformin-Pioglitazone Market Size by Type (2016-2027)
9.3 Latin America Metformin-Pioglitazone Market Size by Application
9.3.1 Latin America Metformin-Pioglitazone Market Size by Application (2016-2021)
9.3.2 Latin America Metformin-Pioglitazone Market Size by Application (2022-2027)
9.3.3 Latin America Metformin-Pioglitazone Market Size by Application (2016-2027)
9.4 Latin America Metformin-Pioglitazone Market Size by Country
9.4.1 Latin America Metformin-Pioglitazone Market Size by Country (2016-2021)
9.4.2 Latin America Metformin-Pioglitazone Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metformin-Pioglitazone Market Size (2016-2027)
10.2 Middle East & Africa Metformin-Pioglitazone Market Size by Type
10.2.1 Middle East & Africa Metformin-Pioglitazone Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metformin-Pioglitazone Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metformin-Pioglitazone Market Size by Type (2016-2027)
10.3 Middle East & Africa Metformin-Pioglitazone Market Size by Application
10.3.1 Middle East & Africa Metformin-Pioglitazone Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metformin-Pioglitazone Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metformin-Pioglitazone Market Size by Application (2016-2027)
10.4 Middle East & Africa Metformin-Pioglitazone Market Size by Country
10.4.1 Middle East & Africa Metformin-Pioglitazone Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metformin-Pioglitazone Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Takeda Pharmaceuticals
11.1.1 Takeda Pharmaceuticals Company Details
11.1.2 Takeda Pharmaceuticals Business Overview
11.1.3 Takeda Pharmaceuticals Metformin-Pioglitazone Introduction
11.1.4 Takeda Pharmaceuticals Revenue in Metformin-Pioglitazone Business (2016-2021)
11.1.5 Takeda Pharmaceuticals Recent Development
11.2 Mylan
11.2.1 Mylan Company Details
11.2.2 Mylan Business Overview
11.2.3 Mylan Metformin-Pioglitazone Introduction
11.2.4 Mylan Revenue in Metformin-Pioglitazone Business (2016-2021)
11.2.5 Mylan Recent Development
11.3 Teva
11.3.1 Teva Company Details
11.3.2 Teva Business Overview
11.3.3 Teva Metformin-Pioglitazone Introduction
11.3.4 Teva Revenue in Metformin-Pioglitazone Business (2016-2021)
11.3.5 Teva Recent Development
11.4 Sandoz
11.4.1 Sandoz Company Details
11.4.2 Sandoz Business Overview
11.4.3 Sandoz Metformin-Pioglitazone Introduction
11.4.4 Sandoz Revenue in Metformin-Pioglitazone Business (2016-2021)
11.4.5 Sandoz Recent Development
11.5 Aurobindo Pharma
11.5.1 Aurobindo Pharma Company Details
11.5.2 Aurobindo Pharma Business Overview
11.5.3 Aurobindo Pharma Metformin-Pioglitazone Introduction
11.5.4 Aurobindo Pharma Revenue in Metformin-Pioglitazone Business (2016-2021)
11.5.5 Aurobindo Pharma Recent Development
11.6 MACLEODS
11.6.1 MACLEODS Company Details
11.6.2 MACLEODS Business Overview
11.6.3 MACLEODS Metformin-Pioglitazone Introduction
11.6.4 MACLEODS Revenue in Metformin-Pioglitazone Business (2016-2021)
11.6.5 MACLEODS Recent Development
11.7 Torrent Pharmaceuticals
11.7.1 Torrent Pharmaceuticals Company Details
11.7.2 Torrent Pharmaceuticals Business Overview
11.7.3 Torrent Pharmaceuticals Metformin-Pioglitazone Introduction
11.7.4 Torrent Pharmaceuticals Revenue in Metformin-Pioglitazone Business (2016-2021)
11.7.5 Torrent Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metformin-Pioglitazone Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Tablets: 15 mg pioglitazone/1000 mg metformin HCl
Table 3. Key Players of Tablets: 30 mg pioglitazone/1000 mg metformin HCl
Table 4. Global Metformin-Pioglitazone Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Metformin-Pioglitazone Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metformin-Pioglitazone Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Metformin-Pioglitazone Market Share by Regions (2016-2021)
Table 8. Global Metformin-Pioglitazone Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Metformin-Pioglitazone Market Share by Regions (2022-2027)
Table 10. Metformin-Pioglitazone Market Trends
Table 11. Metformin-Pioglitazone Market Drivers
Table 12. Metformin-Pioglitazone Market Challenges
Table 13. Metformin-Pioglitazone Market Restraints
Table 14. Global Metformin-Pioglitazone Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Metformin-Pioglitazone Market Share by Players (2016-2021)
Table 16. Global Top Metformin-Pioglitazone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metformin-Pioglitazone as of 2020)
Table 17. Ranking of Global Top Metformin-Pioglitazone Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Metformin-Pioglitazone Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metformin-Pioglitazone Product Solution and Service
Table 21. Date of Enter into Metformin-Pioglitazone Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metformin-Pioglitazone Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Metformin-Pioglitazone Revenue Market Share by Type (2016-2021)
Table 25. Global Metformin-Pioglitazone Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Metformin-Pioglitazone Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Metformin-Pioglitazone Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Metformin-Pioglitazone Revenue Market Share by Application (2016-2021)
Table 29. Global Metformin-Pioglitazone Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Metformin-Pioglitazone Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Metformin-Pioglitazone Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Metformin-Pioglitazone Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Metformin-Pioglitazone Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Metformin-Pioglitazone Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Metformin-Pioglitazone Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Metformin-Pioglitazone Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Metformin-Pioglitazone Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Metformin-Pioglitazone Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Metformin-Pioglitazone Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Metformin-Pioglitazone Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Metformin-Pioglitazone Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Metformin-Pioglitazone Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Metformin-Pioglitazone Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Metformin-Pioglitazone Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Metformin-Pioglitazone Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Metformin-Pioglitazone Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Metformin-Pioglitazone Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Metformin-Pioglitazone Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Metformin-Pioglitazone Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Metformin-Pioglitazone Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Metformin-Pioglitazone Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Metformin-Pioglitazone Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Metformin-Pioglitazone Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Metformin-Pioglitazone Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Metformin-Pioglitazone Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Metformin-Pioglitazone Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Metformin-Pioglitazone Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Metformin-Pioglitazone Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Metformin-Pioglitazone Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Metformin-Pioglitazone Market Size by Country (2022-2027) & (US$ Million)
Table 61. Takeda Pharmaceuticals Company Details
Table 62. Takeda Pharmaceuticals Business Overview
Table 63. Takeda Pharmaceuticals Metformin-Pioglitazone Product
Table 64. Takeda Pharmaceuticals Revenue in Metformin-Pioglitazone Business (2016-2021) & (US$ Million)
Table 65. Takeda Pharmaceuticals Recent Development
Table 66. Mylan Company Details
Table 67. Mylan Business Overview
Table 68. Mylan Metformin-Pioglitazone Product
Table 69. Mylan Revenue in Metformin-Pioglitazone Business (2016-2021) & (US$ Million)
Table 70. Mylan Recent Development
Table 71. Teva Company Details
Table 72. Teva Business Overview
Table 73. Teva Metformin-Pioglitazone Product
Table 74. Teva Revenue in Metformin-Pioglitazone Business (2016-2021) & (US$ Million)
Table 75. Teva Recent Development
Table 76. Sandoz Company Details
Table 77. Sandoz Business Overview
Table 78. Sandoz Metformin-Pioglitazone Product
Table 79. Sandoz Revenue in Metformin-Pioglitazone Business (2016-2021) & (US$ Million)
Table 80. Sandoz Recent Development
Table 81. Aurobindo Pharma Company Details
Table 82. Aurobindo Pharma Business Overview
Table 83. Aurobindo Pharma Metformin-Pioglitazone Product
Table 84. Aurobindo Pharma Revenue in Metformin-Pioglitazone Business (2016-2021) & (US$ Million)
Table 85. Aurobindo Pharma Recent Development
Table 86. MACLEODS Company Details
Table 87. MACLEODS Business Overview
Table 88. MACLEODS Metformin-Pioglitazone Product
Table 89. MACLEODS Revenue in Metformin-Pioglitazone Business (2016-2021) & (US$ Million)
Table 90. MACLEODS Recent Development
Table 91. Torrent Pharmaceuticals Company Details
Table 92. Torrent Pharmaceuticals Business Overview
Table 93. Torrent Pharmaceuticals Metformin-Pioglitazone Product
Table 94. Torrent Pharmaceuticals Revenue in Metformin-Pioglitazone Business (2016-2021) & (US$ Million)
Table 95. Torrent Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metformin-Pioglitazone Market Share by Type: 2020 VS 2027
Figure 2. Tablets: 15 mg pioglitazone/1000 mg metformin HCl Features
Figure 3. Tablets: 30 mg pioglitazone/1000 mg metformin HCl Features
Figure 4. Global Metformin-Pioglitazone Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Metformin-Pioglitazone Report Years Considered
Figure 8. Global Metformin-Pioglitazone Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Metformin-Pioglitazone Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Metformin-Pioglitazone Market Share by Regions: 2020 VS 2027
Figure 11. Global Metformin-Pioglitazone Market Share by Regions (2022-2027)
Figure 12. Global Metformin-Pioglitazone Market Share by Players in 2020
Figure 13. Global Top Metformin-Pioglitazone Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metformin-Pioglitazone as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Metformin-Pioglitazone Revenue in 2020
Figure 15. Global Metformin-Pioglitazone Revenue Market Share by Type (2016-2021)
Figure 16. Global Metformin-Pioglitazone Revenue Market Share by Type (2022-2027)
Figure 17. North America Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Metformin-Pioglitazone Market Share by Type (2016-2027)
Figure 19. North America Metformin-Pioglitazone Market Share by Application (2016-2027)
Figure 20. North America Metformin-Pioglitazone Market Share by Country (2016-2027)
Figure 21. United States Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. Canada Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Europe Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Metformin-Pioglitazone Market Share by Type (2016-2027)
Figure 25. Europe Metformin-Pioglitazone Market Share by Application (2016-2027)
Figure 26. Europe Metformin-Pioglitazone Market Share by Country (2016-2027)
Figure 27. Germany Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. France Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. U.K. Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Italy Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Russia Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Nordic Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Asia-Pacific Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Metformin-Pioglitazone Market Share by Type (2016-2027)
Figure 35. Asia-Pacific Metformin-Pioglitazone Market Share by Application (2016-2027)
Figure 36. Asia-Pacific Metformin-Pioglitazone Market Share by Region (2016-2027)
Figure 37. China Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Japan Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. South Korea Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Southeast Asia Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. India Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Australia Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Latin America Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Metformin-Pioglitazone Market Share by Type (2016-2027)
Figure 45. Latin America Metformin-Pioglitazone Market Share by Application (2016-2027)
Figure 46. Latin America Metformin-Pioglitazone Market Share by Country (2016-2027)
Figure 47. Mexico Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Brazil Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Middle East & Africa Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Metformin-Pioglitazone Market Share by Type (2016-2027)
Figure 51. Middle East & Africa Metformin-Pioglitazone Market Share by Application (2016-2027)
Figure 52. Middle East & Africa Metformin-Pioglitazone Market Share by Country (2016-2027)
Figure 53. Turkey Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Saudi Arabia Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. UAE Metformin-Pioglitazone Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Takeda Pharmaceuticals Revenue Growth Rate in Metformin-Pioglitazone Business (2016-2021)
Figure 57. Mylan Revenue Growth Rate in Metformin-Pioglitazone Business (2016-2021)
Figure 58. Teva Revenue Growth Rate in Metformin-Pioglitazone Business (2016-2021)
Figure 59. Sandoz Revenue Growth Rate in Metformin-Pioglitazone Business (2016-2021)
Figure 60. Aurobindo Pharma Revenue Growth Rate in Metformin-Pioglitazone Business (2016-2021)
Figure 61. MACLEODS Revenue Growth Rate in Metformin-Pioglitazone Business (2016-2021)
Figure 62. Torrent Pharmaceuticals Revenue Growth Rate in Metformin-Pioglitazone Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed

以下、関連資料のご紹介

世界のNASH治療薬市場規模・現状・予測（2021年-2027年）

Global NASH Therapeutic Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4551 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、NASH治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ビタミンE＆ピオグリタゾン、オカリバ、エラフィブラノール、セロンセルチブ＆セニクリビロク）、用途別市場規模（病院薬局、オンラインプロバイダ...

世界のロミプロスティム市場規模・現状・予測（2021年-2027年）

Global Romiplostim Market Size, Status and Forecast 2021-2027
QFJ1-5998 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、ロミプロスティムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250μg/ 0.5mL、500μg/ 1mL）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のルビプロストン市場規模・現状・予測（2021年-2027年）

Global Lubiprostone Market Size, Status and Forecast 2021-2027
QFJ1-5835 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ルビプロストンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（8mcgカプセル、24mcgカプセル）、用途別市場規模（CIC・OIC、IBS-C）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界のリスデキサンフェタミン市場規模・現状・予測（2021年-2027年）

Global Lisdexamfetamine Market Size, Status and Forecast 2021-2027
QFJ1-5832 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、リスデキサンフェタミンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（カプセル、チュアブル錠）、用途別市場規模（成人ADHD、小児ADHD、成人B.E.D.）、主要地域別市場規模（北米、アメリカ、欧州...

世界のデガレリクス市場規模・現状・予測（2021年-2027年）

Global Degarelix Market Size, Status and Forecast 2021-2027
QFJ1-5692 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、デガレリクスの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（バイアル/120mg、バイアル/80mg）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のラパチニブ市場規模・現状・予測（2021年-2027年）

Global Lapatinib Market Size, Status and Forecast 2021-2027
QFJ1-5828 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ラパチニブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（250mg錠、タイプII）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド...

世界のイクサベピロン市場規模・現状・予測（2021年-2027年）

Global Ixabepilone Market Size, Status and Forecast 2021-2027
QFJ1-5813 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、イクサベピロンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（15MG/VIAL、45MG/VIAL）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のヒストレリン市場規模・現状・予測（2021年-2027年）

Global Histrelin Market Size, Status and Forecast 2021-2027
QFJ1-5781 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、ヒストレリンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（サプレリンLA、ヴァンタス）、用途別市場規模（男の子用、女の子用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界のパニツムマブ市場規模・現状・予測（2021年-2027年）

Global Panitumumab Market Size, Status and Forecast 2021-2027
QFJ1-5929 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、パニツムマブの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（100mg/5ml単回投与バイアル、400mg/20ml単回投与バイアル）、用途別市場規模（病院、ドラッグストア）、主要地域別市場規模（北米...

世界のアニデュラファンギン市場規模・現状・予測（2021年-2027年）

Global Anidulafungin Market Size, Status and Forecast 2021-2027
QFJ1-5581 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アニデュラファンギンの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（50mg/各バイアル、100mg/各バイアル）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本...

ピオグリタゾンHCLのグローバル市場調査 2019年 The global Pioglitazone HCL market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Pioglitazone HCL volume and value at global level, regional level and company level. From a global perspective, this repor…
世界のミネラルサプリメント錠剤市場規模・現状・予測（2021年-2027年） Rising prevalence of diseases such as osteoporosis, anemia, cancer, and diabetes is boosting the market growth, as these supplements are commonly used in managing such conditions. Market Analysis and Insights: Global Mineral Supplement Tablets Market The global Mineral Supplement Tablets market size…
カルシウム錠のグローバル市場2021 Calcium tablets are elemental forms of calcium, an essential mineral for human health that may be taken to supplement calcium obtained from dietary sources or to address a calcium deficiency. Most supplements contain one of two forms of calcium—calcium carbonate and calcium citrate. Since vitamin D …
世界のマラビロク市場規模・現状・予測（2021年-2027年） Maraviroc is an antiretroviral drug in the CCR5 receptor antagonist class used in the treatment of HIV infection. Market Analysis and Insights: Global Maraviroc Market The global Maraviroc market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
デジタルライティング＆グラフィックタブレットのグローバル市場2021 This report studies the Digital Writing & Graphics Tablets market, a Digital Writing & Graphics Tablets (also known as a Graphics tablet, digitizer, drawing tablet, digital drawing tablet, pen tablet, or digital art board) is a computer input device that enables a user to hand-draw images, animation…